New research is providing a more detailed view into the structure of the human cannabinoid (CB1) receptor. These findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol (THC)—a primary chemical in marijuana—bind at the CB1 receptor to produce their effects. The research was funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Related posts:
- Medicare, Medicare Card, Receptor Variant Influences, Dopamine Response to Alcohol A genetic variant of a receptor in the brain’s reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. Dopamine is […]...
- Medicare, Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health....
- NIDA, Federal Partners, Launch National Drug Facts Week Expanding on the success of its online Drug Facts Chat Day, the National Institute on Drug Abuse (NIDA) today announced it is launching National Drug Facts Week, a new national awareness week designed to bring together teens and scientific experts to discuss the facts about drug abuse. NIDA is a component of the National Institutes […]...
- Scientists show how gene variant linked to ADHD could operate A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person’s risk for attention-deficit hyperactivity disorder (ADHD). The research, conducted by the Intramural Research Program (IRP) at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, could also […]...
- Common Fund researchers uncover structure of important target for drug design Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor, a type of receptor in cells that can be targeted in the design of new treatments for diseases such as multiple sclerosis. These findings are reported in the Feb. 17 issue of the journal Science. The research was supported […]...
- Medicare Card, Regular marijuana use by teens continues to be a concern Medicare Card, Regular marijuana use by teens continues to be a concern...
- Potential new target for smoking cessation without weight gain A new study uncovers a brain mechanism that could be targeted for new medications designed to help people quit smoking without gaining weight. This research, funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, shows that a specific subclass of brain nicotinic receptor is involved in nicotine’s ability […]...
- HIV/AIDS researcher David Ho wins NIDA’s 2011 Avant-Garde Award The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today that Dr. David Ho of the Aaron Diamond AIDS Research Center in New York, NY, has been selected as the 2011 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research....
- New dates. National Drug Facts Week begins Jan. 28, 2013 The third annual National Drug Facts Week will be held Jan. 28 through Feb. 3, 2013, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today. This week-long observance will bring together teens and scientific experts in community events across the country to discuss scientific facts about drug abuse. […]...
- PEERx for teens to be showcased at Rx Drug Abuse Summit A unique, new campaign targeting teens will be on exhibit at the first national summit addressing the prescription drug abuse epidemic. The National Institute on Drug Abuse (NIDA) will showcase PEERx, a NIDA initiative that uses interactive videos and other tools to educate teens about the dangers of prescription drug abuse and help them to […]...
- Painkiller abuse treated by sustained buprenorphine/naloxone People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday’s Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health....
- New NIDA resource helps families navigate addiction treatment options A new resource, Seeking Drug Abuse Treatment: Know What to Ask, will help individuals and families struggling with addiction ask the right questions before choosing a drug treatment program. It was developed by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and is available to the public free online […]...
- Teen musicians in drug treatment win 2012 Grammy experience Two teens with powerful stories about their experience in drug treatment have been awarded the top distinction in the MusiCares and Grammy Foundation’s Teen Substance Abuse Awareness through Music Contest. The annual contest was created to celebrate National Drug Facts Week and is coordinated by the National Institute on Drug Abuse (NIDA), part of the […]...
- Actress Kathryn Erbe to raise the curtain in NIDA’s Addiction Performance Project Kathryn Erbe leads an impressive cast in the Addiction Performance Project, an innovative continuing medical education (CME) program for doctors and other health providers, on April 16 in the Chicago, Ill. area. The performance is a project of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and is designed […]...
- Medicare Card, Prescription and illicit drug abuse is timely new topic Medicare Card, Prescription and illicit drug abuse is timely new topic ...